Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Finished Goods (2016 - 2025)

INVO Fertility (IVF) has disclosed Finished Goods for 15 consecutive years, with $138148.0 as the latest value for Q3 2025.

  • On a quarterly basis, Finished Goods fell 26.52% to $138148.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $138148.0, a 26.52% decrease, with the full-year FY2024 number at $166227.0, down 21.23% from a year prior.
  • Finished Goods was $138148.0 for Q3 2025 at INVO Fertility, down from $161110.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $222740.0 in Q3 2021 to a low of $138148.0 in Q3 2025.
  • A 5-year average of $195340.4 and a median of $196586.0 in 2024 define the central range for Finished Goods.
  • Peak YoY movement for Finished Goods: soared 104.57% in 2021, then decreased 26.52% in 2025.
  • INVO Fertility's Finished Goods stood at $220168.0 in 2021, then fell by 11.49% to $194879.0 in 2022, then increased by 8.29% to $211028.0 in 2023, then dropped by 21.23% to $166227.0 in 2024, then decreased by 16.89% to $138148.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Finished Goods are $138148.0 (Q3 2025), $161110.0 (Q2 2025), and $163798.0 (Q1 2025).